Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody production
Julia Holstein, Farzan Solimani, Carolin Baum, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 6, pp. 2358-2369
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Development of severe pemphigus vulgaris following SARS‐CoV‐2 vaccination with BNT162b2
Farzan Solimani, Yara E. Mansour, Dario Didona, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 35, Iss. 10
Open Access | Times Cited: 75
T follicular helper cells in autoimmune diseases
Xindi Wei, Xiaoyin Niu
Journal of Autoimmunity (2022) Vol. 134, pp. 102976-102976
Closed Access | Times Cited: 55
Interleukin‐21 in autoimmune and inflammatory skin diseases
Alberto Mesas‐Fernández, Euna Bodner, Franz J. Hilke, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 4
Open Access | Times Cited: 29
Immunopathology and Immunotherapy of Inflammatory Skin Diseases
Ahreum Song, Sang Eun Lee, Jong Hoon Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
Hisato Iriki, Hayato Takahashi, Masayuki Amagai
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 4, pp. 545-553
Open Access | Times Cited: 18
Disease modification in chronic spontaneous urticaria
Marcus Maurer, Pavel Kolkhir, Manuel P. Pereira, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2396-2413
Open Access | Times Cited: 7
Autoimmune Pemphigus: Latest Advances and Emerging Therapies
Yen Loo Lim, G. Bohelay, Sho Hanakawa, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 26
A Novel Combined Use of Dupilumab for Treatment of Aggressive Refractory Pemphigus Vulgaris Complicated With Pulmonary Tuberculosis: A Case Report and the RNA-seq Analysis
Siji Chen, Shaowei Zhan, Chunting Hua, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
Maud Maho‐Vaillant, Magdalena Sips, Marie-Laure Golinski, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy
Dario Didona, Morna F. Schmidt, Roberto Maglie, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2023) Vol. 21, Iss. 10, pp. 1188-1209
Open Access | Times Cited: 15
Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
Rebekah R. Schwartz, Kristina Seiffert-Sinha, Animesh A. Sinha
Frontiers in Immunology (2025) Vol. 15
Open Access
Meeting report – Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseases
Jens Waschke, Masayuki Amagai, Christoph Becker, et al.
Journal of Cell Science (2025) Vol. 138, Iss. 2
Closed Access
Distinct anti-microbial peptides expression patterns and microbiome profiles in skin of Tunisian endemic Pemphigus foliaceus patients
Olfa Abida, Ricardo S. Ramiro, E. Bahloul, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies
Wenzhe Zhao, Jingying Wang, Haiqin Zhu, et al.
Clinical Reviews in Allergy & Immunology (2021) Vol. 61, Iss. 3, pp. 351-362
Closed Access | Times Cited: 27
Esophageal lichen planus: Current knowledge, challenges and future perspectives
Annegrit Decker, Franziska Schauer, Adhara Lazaro, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 41, pp. 5893-5909
Open Access | Times Cited: 19
Development of pemphigus vulgaris after the second dose of the mRNA‐1273 SARS‐Cov‐2 vaccine
Ioannis G. Koutlas, Renee Camara, Prokopios P. Argyris, et al.
Oral Diseases (2021) Vol. 28, Iss. S2, pp. 2612-2613
Closed Access | Times Cited: 25
Transcriptomic profiling of pemphigus lesion infiltrating mononuclear cells reveals a distinct local immune microenvironment and novel lncRNA regulators
Zixuan Huang, Peng Qu, Kankan Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Mouse models of pemphigus: valuable tools to investigate pathomechanisms and novel therapeutic interventions
Shirin Emtenani, Michael Hertl, Enno Schmidt, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
Haley Starr, Elizabeth W. Howerth, Renato Leon, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 2, pp. 89-89
Open Access | Times Cited: 3
New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies
Aref Ghanaatpisheh, Mohadesseh Safari, Hoda Haghshenas, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
What is novel in the clinical management of pemphigus vulgaris?
Ahmad Vafaeian, Hamidreza Mahmoudi, Maryam Daneshpazhooh
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 5-6, pp. 489-503
Closed Access | Times Cited: 3
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus
Christoph Hudemann, Roberto Maglie, Maria Llamazares Prada, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 3, pp. 915-923.e3
Closed Access | Times Cited: 22
Oral lesions after COVID-19 vaccination: Immune mechanisms and clinical approach
Mohammad Amin Khazeei Tabari, Shaghayegh Najary, Gita Khadivi, et al.
Infectious Medicine (2022) Vol. 1, Iss. 3, pp. 171-179
Open Access | Times Cited: 13
Targeting Th17 cells: a promising strategy to treat oral mucosal inflammatory diseases
Ying Wang, Ningning Xue, Ziyuan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris
V. Hébert, Julien Novarino, Maud Maho‐Vaillant, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 605-615
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top